Orlen S.A. (LON:0FMN)
92.85
-2.73 (-2.86%)
At close: Nov 27, 2025
Orlen Revenue
Orlen had revenue of 61.01B PLN in the quarter ending September 30, 2025, a decrease of -10.20%. This brings the company's revenue in the last twelve months to 270.40B, down -14.80% year-over-year. In the year 2024, Orlen had annual revenue of 294.98B, down -20.69%.
Revenue (ttm)
270.40B PLN
Revenue Growth
-14.80%
P/S Ratio
0.40
Revenue / Employee
3.99M PLN
Employees
67,809
Market Cap
22.29B GBP
Revenue Chart
* This company reports financials in PLN.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 294.98B | -76.94B | -20.69% |
| Dec 31, 2023 | 371.92B | 89.50B | 31.69% |
| Dec 31, 2022 | 282.42B | 151.07B | 115.02% |
| Dec 31, 2021 | 131.34B | 45.16B | 52.40% |
| Dec 31, 2020 | 86.18B | -25.02B | -22.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |